Imprimis NJOF Recalls
21 recalls on record · January 6, 2021 to January 14, 2026 · Drugs
Recalls by year
21
23
24
25
26
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
January 14, 2026DrugsFDA
Imprimis NJOF, LLC recalls Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC.
Hazard: Presence of particulate matter - Glass like particles.
January 14, 2026DrugsFDA
Imprimis NJOF, LLC recalls Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF,
Hazard: Presence of particulate matter - Glass like particles.
January 14, 2026DrugsFDA
Imprimis NJOF, LLC recalls Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, N
Hazard: Presence of particulate matter - Glass like particles.
November 26, 2025DrugsFDA
Imprimis NJOF, LLC recalls Klarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a compounded drug, Office Us
Hazard: Subpotent Drug
July 30, 2025DrugsFDA
Imprimis NJOF, LLC recalls Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5ML vial per ca
Hazard: Sub-Potent Drug: Subpotent assay results during stability testing.
July 30, 2025DrugsFDA
Imprimis NJOF, LLC recalls Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705 Route 46 Wes
Hazard: Sub-Potent Drug: Subpotent assay results during stability testing.
April 9, 2025DrugsFDA
Imprimis NJOF, LLC recalls Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5 mL fill in 15
Hazard: Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.
June 19, 2024DrugsFDA
Imprimis NJOF, LLC recalls Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL, Quantity: 20mL, Rx Only, Compo
Hazard: Lack of Assurance of Sterility
June 19, 2024DrugsFDA
Imprimis NJOF, LLC recalls Klarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion 0.1% 5.5mL, Rx Only, This is a compounded drug. N
Hazard: Lack of Assurance of Sterility
June 5, 2024DrugsFDA
Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vial for Intraocular Injection, Impr
Hazard: Lack of Assurance of Sterility
June 5, 2024DrugsFDA
Imprimis NJOF, LLC recalls Moxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC
Hazard: Lack of Assurance of Sterility
June 5, 2024DrugsFDA
Imprimis NJOF, LLC recalls Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, L
Hazard: Lack of Assurance of Sterility
June 5, 2024DrugsFDA
Imprimis NJOF, LLC recalls Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL, 0.5 mg/mL and 0.4 mg/mL), Preservative-Free, 1mL Single-Use vials for Int
Hazard: Lack of Assurance of Sterility
June 5, 2024DrugsFDA
Imprimis NJOF, LLC recalls Dexamethasone-Moxifloxacin (1 mg/mL and 5mg/mL) Preservative-Free, 1mL Single-Use vials for Intraocular Injection, Rx on
Hazard: Lack of Assurance of Sterility
June 5, 2024DrugsFDA
Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vials for Intraocular Injection, Imp
Hazard: Lack of Assurance of Sterility
May 8, 2024DrugsFDA
Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free, 1 mL Single-Use vials, Rx only, Imprimis NJOF, LL
Hazard: Out of specification for assay
May 8, 2024DrugsFDA
Imprimis NJOF, LLC recalls Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: I
Hazard: Subpotent Drug
October 25, 2023DrugsFDA
Imprimis NJOF, LLC recalls MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution Drops 1% - 0.5% - 2.5% -
Hazard: Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim.
October 11, 2023DrugsFDA
Imprimis NJOF, LLC recalls Epinephrine-Lidocaine HCl (0.25mg/mL and 7.5mg/mL) 1mL Single Use Intraocular injection Preservative Free NDC 71384-640-
Hazard: Subpotent: Failing Test Results for Epinephrine
August 30, 2023DrugsFDA
Imprimis NJOF, LLC recalls Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%, 5mL bottle, Imprimis NJOF, LLC. 1705 Route 46 West,
Hazard: Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.
January 6, 2021DrugsFDA
Imprimis NJOF, LLC recalls Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Imprimis NJOF, LLC. 1705 Route 46 W
Hazard: Lack of assurance of sterility: 13 vials were discovered to have faulty crimps.